Home > Official notices > Statutory Committee inquiries  |  Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7476 p512-513
3 November 2007


Statutory Committee inquiries

The Statutory Committee of the Royal Pharmaceutical Society of Great Britain met on Monday 22, Tuesday 23, Wednesday 24 and Thursday 25 October 2007, and made the following decisions:

1. Following the inquiry into the case of Viviane Andraous (registration number 1078359) the committee resolved to issue Mrs Andraous with a reprimand. The committee will deliver its full determination at a later date.

2. Following the inquiry into the case of John Joseph George Barnes (registration number 62087) the committee adjourned to resume at a later date.

3. Following the inquiry into the case of Shiv Kumar Sharma (registration number 90720) the committee adjourned to resume at a later date.

4. Following the inquiry into the case of Girish Balvantrai Desai (registration number 66679) the committee resolved to issue Mr Desai with a reprimand. The committee found proved that the supply of metformin 500mg tablets at a dose of one tablet twice daily without the authority of a prescription; the supply of gliclazide 80mg tablets at a dose of one in the morning and two at night against a prescription calling for gliclazide 80mg tablets at a dose of one in the morning; the supply of four dosette boxes which were not labelled to indicate (a) the name and address of supplier, (b) date on which product was dispensed, (c) name of product supplied, (d) directions for use, (e) precautions relating to use; and (f) name of patient (in relation to three of the four dosette boxes); erroneously informing a daughter of a patient that a prescription had not changed from previous prescriptions in answer to a query; failing to check the prescription before answering the above query; failing to provide PILs unless a patient specifically asked for one; failing to provide a PIL if a patient received new medicine in a dosette box, amounted to misconduct. The committee further directed that no further action should be taken against Lemongold Ltd (identification number 1002073).

Fitness to Practise Committees Secretariat

Back to Top


©The Pharmaceutical Journal